Advertisement

February 10, 2020

FDA Clears Rist Neurovascular’s Rist Cath for Radial Access

February 10, 2020—Rist Neurovascular, Inc. announced it has received FDA 510(k) clearance to market the Rist Cath radial access long sheath for the introduction of interventional devices into the peripheral, coronary, and neurovascular system. The Rist Cath is specifically designed for accessing the neurovasculature through the radial artery, enabling the full gamut of neurovascular procedures to be performed transradially.

In the company’s announcement, Pascal M. Jabbour, MD, commented, “Although transradial techniques have become the standard of care in the cardiac interventional communities, neurointerventionalists have not previously had the appropriate tools to allow these advantages for patients undergoing neurovascular procedures. Clearance of the Rist Cath provides neuroendovascular specialists a safe and durable tool to perform neuroendovascular interventions via a transradial approach and allows us to offer improved care for patients while pushing the envelope of what our field has to offer.”

Dr. Jabbour is Professor of Neurological Surgery and Chief of the Division of Neurovascular and Endovascular Neurosurgery in the Department of Neurological Surgery at the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, Pennsylvania.

Advertisement


February 10, 2020

One-Year Outcomes Published From CLI Substudy of LIBERTY 360º

February 6, 2020

Dorothy Abel Joins Syntactx as Vice President, Regulatory Strategy